The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biopharma Contract Manufacturing-Global Market Insights and Sales Trends 2025
Synopsis
The global Biopharma Contract Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biopharma Contract Manufacturing in various end use industries. The expanding demands from the Small Medium Enterprise and Large Enterprise, are propelling Biopharma Contract Manufacturing market. Manufacturing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Research segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharma Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharma Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharma Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharma Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharma Contract Manufacturing covered in this report include Catalent, Pharmaceutical Product Development LLC, AbbVie, Baxter BioPharma Solutions, Patheon, Grifols International, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmBh and Lonza AG., etc.
The global Biopharma Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Catalent
Pharmaceutical Product Development LLC
AbbVie
Baxter BioPharma Solutions
Patheon
Grifols International
Dalton Pharma Services
Boehringer Ingelheim Biopharmaceuticals GmBh
Lonza AG.
QuintilesIMS
Vetter Pharma
Ligand Pharmaceuticals, Inc.
Bausch Health
Recipharm AB
Famar Health Care Services
West Pharmaceutical Services, Inc.
Global Biopharma Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharma Contract Manufacturing market, Segment by Type:
Manufacturing
Research
Global Biopharma Contract Manufacturing market, by Application
Small Medium Enterprise
Large Enterprise
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharma Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Biopharma Contract Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biopharma Contract Manufacturing in various end use industries. The expanding demands from the Small Medium Enterprise and Large Enterprise, are propelling Biopharma Contract Manufacturing market. Manufacturing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Research segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharma Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharma Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharma Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharma Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharma Contract Manufacturing covered in this report include Catalent, Pharmaceutical Product Development LLC, AbbVie, Baxter BioPharma Solutions, Patheon, Grifols International, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmBh and Lonza AG., etc.
The global Biopharma Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Catalent
Pharmaceutical Product Development LLC
AbbVie
Baxter BioPharma Solutions
Patheon
Grifols International
Dalton Pharma Services
Boehringer Ingelheim Biopharmaceuticals GmBh
Lonza AG.
QuintilesIMS
Vetter Pharma
Ligand Pharmaceuticals, Inc.
Bausch Health
Recipharm AB
Famar Health Care Services
West Pharmaceutical Services, Inc.
Global Biopharma Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharma Contract Manufacturing market, Segment by Type:
Manufacturing
Research
Global Biopharma Contract Manufacturing market, by Application
Small Medium Enterprise
Large Enterprise
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharma Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biopharma Contract Manufacturing
1.1 Biopharma Contract Manufacturing Market Overview
1.1.1 Biopharma Contract Manufacturing Product Scope
1.1.2 Biopharma Contract Manufacturing Market Status and Outlook
1.2 Global Biopharma Contract Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biopharma Contract Manufacturing Market Size by Region (2018-2029)
1.4 Global Biopharma Contract Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Biopharma Contract Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biopharma Contract Manufacturing Market Size (2018-2029)
1.6.1 North America Biopharma Contract Manufacturing Market Size (2018-2029)
1.6.2 Europe Biopharma Contract Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Biopharma Contract Manufacturing Market Size (2018-2029)
1.6.4 Latin America Biopharma Contract Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Biopharma Contract Manufacturing Market Size (2018-2029)
2 Biopharma Contract Manufacturing Market by Type
2.1 Introduction
2.1.1 Manufacturing
2.1.2 Research
2.2 Global Biopharma Contract Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biopharma Contract Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Biopharma Contract Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biopharma Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biopharma Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biopharma Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biopharma Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biopharma Contract Manufacturing Revenue Breakdown by Type (2018-2029)
3 Biopharma Contract Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Small Medium Enterprise
3.1.2 Large Enterprise
3.2 Global Biopharma Contract Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biopharma Contract Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Biopharma Contract Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biopharma Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biopharma Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biopharma Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biopharma Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biopharma Contract Manufacturing Revenue Breakdown by Application (2018-2029)
4 Biopharma Contract Manufacturing Competition Analysis by Players
4.1 Global Biopharma Contract Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharma Contract Manufacturing as of 2022)
4.3 Date of Key Players Enter into Biopharma Contract Manufacturing Market
4.4 Global Top Players Biopharma Contract Manufacturing Headquarters and Area Served
4.5 Key Players Biopharma Contract Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Biopharma Contract Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Catalent
5.1.1 Catalent Profile
5.1.2 Catalent Main Business
5.1.3 Catalent Biopharma Contract Manufacturing Products, Services and Solutions
5.1.4 Catalent Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 Catalent Recent Developments
5.2 Pharmaceutical Product Development LLC
5.2.1 Pharmaceutical Product Development LLC Profile
5.2.2 Pharmaceutical Product Development LLC Main Business
5.2.3 Pharmaceutical Product Development LLC Biopharma Contract Manufacturing Products, Services and Solutions
5.2.4 Pharmaceutical Product Development LLC Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 Pharmaceutical Product Development LLC Recent Developments
5.3 AbbVie
5.3.1 AbbVie Profile
5.3.2 AbbVie Main Business
5.3.3 AbbVie Biopharma Contract Manufacturing Products, Services and Solutions
5.3.4 AbbVie Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 Baxter BioPharma Solutions Recent Developments
5.4 Baxter BioPharma Solutions
5.4.1 Baxter BioPharma Solutions Profile
5.4.2 Baxter BioPharma Solutions Main Business
5.4.3 Baxter BioPharma Solutions Biopharma Contract Manufacturing Products, Services and Solutions
5.4.4 Baxter BioPharma Solutions Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 Baxter BioPharma Solutions Recent Developments
5.5 Patheon
5.5.1 Patheon Profile
5.5.2 Patheon Main Business
5.5.3 Patheon Biopharma Contract Manufacturing Products, Services and Solutions
5.5.4 Patheon Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 Patheon Recent Developments
5.6 Grifols International
5.6.1 Grifols International Profile
5.6.2 Grifols International Main Business
5.6.3 Grifols International Biopharma Contract Manufacturing Products, Services and Solutions
5.6.4 Grifols International Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 Grifols International Recent Developments
5.7 Dalton Pharma Services
5.7.1 Dalton Pharma Services Profile
5.7.2 Dalton Pharma Services Main Business
5.7.3 Dalton Pharma Services Biopharma Contract Manufacturing Products, Services and Solutions
5.7.4 Dalton Pharma Services Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 Dalton Pharma Services Recent Developments
5.8 Boehringer Ingelheim Biopharmaceuticals GmBh
5.8.1 Boehringer Ingelheim Biopharmaceuticals GmBh Profile
5.8.2 Boehringer Ingelheim Biopharmaceuticals GmBh Main Business
5.8.3 Boehringer Ingelheim Biopharmaceuticals GmBh Biopharma Contract Manufacturing Products, Services and Solutions
5.8.4 Boehringer Ingelheim Biopharmaceuticals GmBh Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 Boehringer Ingelheim Biopharmaceuticals GmBh Recent Developments
5.9 Lonza AG.
5.9.1 Lonza AG. Profile
5.9.2 Lonza AG. Main Business
5.9.3 Lonza AG. Biopharma Contract Manufacturing Products, Services and Solutions
5.9.4 Lonza AG. Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Lonza AG. Recent Developments
5.10 QuintilesIMS
5.10.1 QuintilesIMS Profile
5.10.2 QuintilesIMS Main Business
5.10.3 QuintilesIMS Biopharma Contract Manufacturing Products, Services and Solutions
5.10.4 QuintilesIMS Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 QuintilesIMS Recent Developments
5.11 Vetter Pharma
5.11.1 Vetter Pharma Profile
5.11.2 Vetter Pharma Main Business
5.11.3 Vetter Pharma Biopharma Contract Manufacturing Products, Services and Solutions
5.11.4 Vetter Pharma Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 Vetter Pharma Recent Developments
5.12 Ligand Pharmaceuticals, Inc.
5.12.1 Ligand Pharmaceuticals, Inc. Profile
5.12.2 Ligand Pharmaceuticals, Inc. Main Business
5.12.3 Ligand Pharmaceuticals, Inc. Biopharma Contract Manufacturing Products, Services and Solutions
5.12.4 Ligand Pharmaceuticals, Inc. Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.12.5 Ligand Pharmaceuticals, Inc. Recent Developments
5.13 Bausch Health
5.13.1 Bausch Health Profile
5.13.2 Bausch Health Main Business
5.13.3 Bausch Health Biopharma Contract Manufacturing Products, Services and Solutions
5.13.4 Bausch Health Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.13.5 Bausch Health Recent Developments
5.14 Recipharm AB
5.14.1 Recipharm AB Profile
5.14.2 Recipharm AB Main Business
5.14.3 Recipharm AB Biopharma Contract Manufacturing Products, Services and Solutions
5.14.4 Recipharm AB Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.14.5 Recipharm AB Recent Developments
5.15 Famar Health Care Services
5.15.1 Famar Health Care Services Profile
5.15.2 Famar Health Care Services Main Business
5.15.3 Famar Health Care Services Biopharma Contract Manufacturing Products, Services and Solutions
5.15.4 Famar Health Care Services Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.15.5 Famar Health Care Services Recent Developments
5.16 West Pharmaceutical Services, Inc.
5.16.1 West Pharmaceutical Services, Inc. Profile
5.16.2 West Pharmaceutical Services, Inc. Main Business
5.16.3 West Pharmaceutical Services, Inc. Biopharma Contract Manufacturing Products, Services and Solutions
5.16.4 West Pharmaceutical Services, Inc. Biopharma Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.16.5 West Pharmaceutical Services, Inc. Recent Developments
6 North America
6.1 North America Biopharma Contract Manufacturing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Biopharma Contract Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biopharma Contract Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biopharma Contract Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biopharma Contract Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biopharma Contract Manufacturing Market Dynamics
11.1 Biopharma Contract Manufacturing Industry Trends
11.2 Biopharma Contract Manufacturing Market Drivers
11.3 Biopharma Contract Manufacturing Market Challenges
11.4 Biopharma Contract Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
